Hi-Tech Pharmacal Co. (HITK) Misses Q1 EPS by 24c; Sales Light

Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q1 EPS of $0.44, $0.24 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $52 million versus the consensus estimate of $57.6 million.

NOTE: Shares were halted.

For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Fort Technology posts 49% revenue rise in first half of 2026
• Yeti Holdings Inc. (YETI) PT Raised to $45 at Stifel on Beat and Raise Q2 Results